Perinatal Outcomes of Late Preterm Rupture of Membranes with or without Latency Antibiotics

Abstract

Objective This study aimed to examine whether the addition of latency antibiotics in late preterm rupture of membranes (ROM) decreases neonatal infection and increases latency.

Study Design This retrospective two-center study was conducted at Holy Family Hospital (HFH) in Nazareth and Emek Medical Center (EMC) in Afula, on data collected between January 2017 and April 2023. HFH is the smaller institution. EMC and HFH implement similar policies regarding ROM at 34^0/7 to 36^6/7 weeks' gestation; the only difference is that a 10-day course of latency antibiotics is implemented at EMC. All women with ROM between 34^0/7 and 36^6/7 weeks' gestation who were admitted to one of the centers during the study period, and had a live fetus without major malformations, were included. The primary outcome was neonatal sepsis rate. Secondary outcomes included a composite of neonatal sepsis, mechanical ventilation ≥24 hours, and perinatal death. Additionally, gestational age at delivery and delivery mode were examined.

Results Overall, 721 neonates were delivered during the study period: 534 at EMC (where latency antibiotics were administered) and 187 at HFH. The gestational age at ROM was similar (35.8 and 35.9 weeks, respectively, p = 0.14). Neonatal sepsis occurred in six (1.1%) neonates at EMC and one (0.5%) neonate at HFH (adjusted p = 0.71; OR: 1.69; 95% Confidence Interval [CI]: 0.11–27.14). The composite secondary outcome occurred in nine (1.7%) and three (1.6%) neonates at EMC and HFH, respectively (adjusted p = 0.71; OR: 0.73; 95% CI: 0.14–3.83). The gestational age at delivery was 36.1 and 36.2 weeks at EMC and HFH, respectively (mean difference: 5 h; adjusted p = 0.02). The cesarean delivery rate was 24.7% and 19.3% at EMC and HFH, respectively (adjusted p = 0.96).

Conclusion Latency antibiotics administered to women admitted with ROM between 34^0/7 and 36^6/7 weeks' gestation did not decrease the rate of neonatal sepsis.

Key Points

• Latency antibiotics in late preterm ROM does not decrease neonatal sepsis.

• Latency antibiotics in late preterm ROM does not prolong gestational age at delivery.

• Latency antibiotics in late preterm ROM does not affect the mode of delivery.

Keywords

expectant management - latency antibiotics - neonatal sepsis - late preterm rupture of membranes

Publication History

Received: 12 January 2024

Accepted: 06 March 2024

Accepted Manuscript online:
07 March 2024

Article published online:
26 March 2024

• References

• 1 Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG 2005; 112 (Suppl. 01) 32-37
• 2 Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol 1991; 164 (5 Pt 1): 1317-1326
• 3 Daikoku NH, Kaltreider DF, Johnson Jr TR, Johnson JW, Simmons MA. Premature rupture of membranes and preterm labor: neonatal infection and perinatal mortality risks. Obstet Gynecol 1981; 58 (04) 417-425
• 4 Hannah ME, Ohlsson A, Farine D. et al; TERMPROM Study Group. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. N Engl J Med 1996; 334 (16) 1005-1010
• 5 Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101 (01) 178-193
• 6 Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992; 79 (01) 75-80
• 7 Gaudet LM, Smith GN. Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv 2001; 56 (07) 433-436
• 8 Wu YW, Colford Jr JM. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284 (11) 1417-1424
• 9 Mercer BM, Miodovnik M, Thurnau GR. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. JAMA 1997; 278 (12) 989-995
• 10 Kenyon SL, Taylor DJ, Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001; 357 (9261) 979-988
• 11 Mercer B. Antibiotics in the management of PROM and preterm labor. Obstet Gynecol Clin North Am 2012; 39 (01) 65-76
• 12 Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013; 12 (12) CD001058
• 13 American College of Obstetricians and Gynecologists. Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol 2020; 135 (03) e80-e97
• 14 Royal College of Obstetricians and Gynaecologists. Care of women presenting with suspected preterm prelabour rupture of membranes from 24+0 weeks of gestation. Green-top Guideline 2019; (73) e153-e166
• 15 Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics 2004; 114 (02) 372-376
• 16 Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, Reijneveld SA, Bos AF. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics 2012; 130 (02) e265-e272
• 17 Hibbard JU, Wilkins I, Sun L. et al; Consortium on Safe Labor. Respiratory morbidity in late preterm births. JAMA 2010; 304 (04) 419-425
• 18 Morris JM, Roberts CL, Bowen JR. et al; PPROMT Collaboration. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet 2016; 387 (10017): 444-452
• 19 Chiossi G, Di Tommaso M, Monari F. et al. Neonatal outcomes and risk of neonatal sepsis in an expectantly managed cohort of late preterm prelabor rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2021; 261: 1-6
• 20 van der Ham DP, Vijgen SM, Nijhuis JG. et al; PPROMEXIL trial group. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Med 2012; 9 (04) e1001208
• 21 van der Ham DP, van der Heyden JL, Opmeer BC. et al. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol 2012; 207 (04) 276.e1-276.e10
• 22 Bond DM, Middleton P, Levett KM. et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev 2017; 3 (03) CD004735
• 23 Gyamfi-Bannerman C, Thom EA, Blackwell SC. et al; NICHD Maternal–Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374 (14) 1311-1320
• 24 Chong CYL, Bloomfield FH, O'Sullivan JM. Factors affecting gastrointestinal microbiome development in neonates. Nutrients 2018; 10 (03) 274